Alejandra Manjarrez, PhD
Alejandra Manjarrez joined Drug Discovery News as an assistant editor in 2023. She earned her PhD from ETH Zurich, Switzerland, in 2018, and has written for The Scientist, Science, Knowable Magazine, The Atlantic, and others. She is an inveterate reader and dancer, and likes travelling.
Articles by Alejandra Manjarrez, PhD
| 8 min read
Bacteria from healthy vaginas show promise in protecting women from pathogens, but advancing their development requires more funding and research.
| 3 min read
Sagimet’s denifanstat delivered significant improvements in disease activity and fibrosis for patients with metabolic dysfunction-associated steatohepatitis.
| 3 min read
A small percentage of cells in healthy breast tissue show chromosomal abnormalities often linked to cancer, a finding with potential diagnostic implications.
| 4 min read
Novartis’ iscalimab may improve troubling symptoms in patients with Sjögren’s disease, though there may be safety concerns to address.
| 7 min read
The link between metabolism and sleep is helping scientists find new biomarkers to detect sleepless nights and diagnose chronic sleep disorders.
| 4 min read
Microparticle injections containing an immunomodulator protein inhibited bone loss and promoted repair in a mouse model of periodontal disease.
| 5 min read
Breast cancer cells can pass through the bone marrow to reach the tissues surrounding the brain and spinal cord in mice — a new way for cancer to spread.
| 9 min read
Rodent studies and clinical trials increasingly demonstrate the soothing effects of green light, and now, researchers are revealing the underlying neural mechanisms.
| 8 min read
3D bioprinted models of the tumor microenvironment could make the preclinical research process more reliable and accelerate translation to the clinic.
| 6 min read
Researchers harvest stem cells from patients who have recently had a heart attack and use them to trigger regeneration of their cardiac muscle.
| 6 min read
Researchers use cell-free DNA circulating in the blood of patients with rheumatoid arthritis to match them with the most effective drugs.
| 8 min read
An understudied melanoma arises without sun exposure, but researchers are beginning to shed light on this challenging form of skin cancer.
| 4 min read
A dermatologist and a nanomaterials scientist teamed up to develop synthetic particles to accelerate tissue repair in damaged skin.
| 10+ min read
Scientists weaponize the symbiotic bacteria in mosquitoes against the deadly diseases they transmit.
| 3 min read
Targeting a gut microbial enzyme could potentially improve treatment for type 2 diabetes.
Page 1 of 2 - 25 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Harnessing liver-on-a-chip models for drug safety
Discover how researchers leverage microphysiological systems in toxicology studies.
Enhancing bioanalytical studies with centralized data management
Learn how researchers can improve compliance and efficiency with advanced LIMS solutions.
Explained: How are metabolite biomarkers improving drug discovery and development?
By offering a rich source of insights into disease and drugs, metabolite biomarkers are at the forefront of therapeutic exploration.
